Investigation of the tissue specific role for IKK beta in inflammation and immunity. (360G-Wellcome-081093_Z_06_Z)

£223,187

Nuclear Factor (NF)-kB is a ubiquitous transcription factor with important roles in inflammation and immunity. My previous research has suggested a role for NF-kB in the resolution of inflammation in vivo (Nat Med 7:1291-7 2001). This project is centred on my discovery of a tissue specific role for NF-kB in inflammation, revealed by Cre/lox mediated gene targeting of IkB kinase (IKK) ß in lung epithelial cells and myeloid cells, presented as preliminary data in the proposal. These experiments uncovered a new function for IKKß in suppression of the 'classically' activated macrophage phenotype. The research proposed will further establish the hypothesis that NF-kB plays a tissue specific role in inflammation by generating new transgenic mouse lines and extending the in vivo analysis to models of both acute and chronic inflammation. Further in vitro studies will characterise the role of IKKß in the regulation of macrophage function and activation and define the molecular mechanism for the suppression of macrophage activation by IKKß. The key goals of this proposal are:Characterise the role of IKKß and NF-kB in the suppression of inflammatory macrophage activation.Determine the specific roles of IKKß in fibroblasts and macrophages in acute inflammation and antigen-driven chronic inflammation.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 223187
Applicant Surname Lawrence
Approval Committee Immunology and Infectious Disease Funding Committee
Award Date 2006-10-19T00:00:00+00:00
Financial Year 2006/07
Grant Programme: Title Project Grant
Internal ID 081093/Z/06/Z
Lead Applicant Dr Toby Lawrence
Partnership Value 223187
Planned Dates: End Date 2009-06-30T00:00:00+00:00
Planned Dates: Start Date 2007-09-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region Greater London